Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
Longterm Followup Finds Taxotere Improves Survival
Drug Combination Tested For B.C. Brain Metastases
Sunitinib May Be Associated With Cardiac Toxicity
BRCA Carriers Live Longer Than Those With Normal Gene
Rev/Vel/Dex Response Rate High In Phase I/II Study
FDA Approves Genetic Test For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies